These findings are extendable to other tumor types, since MEF2D‐ITGB1‐ITGB4 signature was also co‐expressed (Figure S3G, Supporting Information) and correlated to shortened OS and disease‐free survival (DFS) in multiple human cancers (Figure S10D, Supporting Information). Here, ITGB4 is linked to cancer.